DataMEDS AI Launches New Corporate Website
Analysis based on 7 articles · First reported Sep 21, 2026 · Last updated Sep 21, 2026
The website launch is a minor corporate communications event with negligible immediate impact on DataMeds AI's stock or the broader market, as it discloses no new financial results or material transactions. Investor attention will likely remain focused on the previously announced Helomics acquisition, the litigation settlement, and the pending multi-party transaction involving Datavault AI, Scilex Holding Company, EOS Holdings and HealthBridge Advisors.
DataMeds AI, Inc. (NASDAQ:MEDS), a Tampa-based Health IT company formerly known as Wellgistics, Inc., announced on September 21, 2026 the launch of its new corporate website, www.DataMedsAI.com. The company said the updated site aligns with pending marketing initiatives and reflects its new AI-centric branding following the recent closing of its acquisition of Helomics Corporation's artificial intelligence Cancer Diagnostics Lab from Axe Compute, and the settlement of outstanding litigation that extinguished approximately $19 million in liabilities and retired 364,099 common shares. Interim Co-CEO Gerald Commissiong stated that with the Helomics acquisition closed and litigation related to the May 11, 2023 acquisition of Wellgistics, LLC settled, the company is poised to launch its Health Lives Here consumer application and intends to soft launch the app in short order. DataMEDS describes itself as vertically integrating technology, pharmacy, pharmaceutical-adjacent and telemedicine business units, incorporating the EinsteinRx artificial intelligence platform and the PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application, while its Corexa Health subsidiary provides pharmacy and pharmacy services, including distribution of products developed by Tollo Health. The press release also references a proposed transaction with Datavault AI Inc. (NASDAQ:DVLT), Scilex Holding Company, EOS Holdings and HealthBridge Advisors, subject to closing conditions and stockholder approval. The announcement is a routine corporate communications update with no direct financial figures disclosed beyond the previously reported liability extinguishment and share retirement.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard